On the grounds that miRNAs present in the blood of prostate cancer (PCa) patients are released in the growth medium by PCa cells, it is conceivable that PCa cells resistant to docetaxel (DCT) (DCT(R)) will release miRNAs that may be found in PCa patients under DCT therapy if resistant PCa cells appear.